CEBPA and fibrosis: Aged livers are more susceptible to pharmacological therapies and are more likely to develop liver diseases such steatosis, cirrhosis, and fibrosis, at least partly due to increased p-C/EBPα-S193 caused by increased CyclinD3/CDK4 activity [73, 75, 142].